- Home
- TCRX vs ABVE Comparison
TCRX vs ABVE Comparison
Compare TCRX & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- ABVE
- Stock Information
- Founded
- TCRX 2018
- ABVE 2019
- Country
- TCRX United States
- ABVE Canada
- Employees
- TCRX N/A
- ABVE N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- ABVE Packaged Foods
- Sector
- TCRX Health Care
- ABVE Consumer Staples
- Exchange
- TCRX Nasdaq
- ABVE Nasdaq
- Market Cap
- TCRX 91.7M
- ABVE 90.1M
- IPO Year
- TCRX 2021
- ABVE N/A
- Fundamental
- Price
- TCRX $1.91
- ABVE $1.65
- Analyst Decision
- TCRX Strong Buy
- ABVE
- Analyst Count
- TCRX 5
- ABVE 0
- Target Price
- TCRX $9.40
- ABVE N/A
- AVG Volume (30 Days)
- TCRX 208.8K
- ABVE 1.7M
- Earning Date
- TCRX 08-12-2025
- ABVE 01-01-0001
- Dividend Yield
- TCRX N/A
- ABVE N/A
- EPS Growth
- TCRX N/A
- ABVE N/A
- EPS
- TCRX N/A
- ABVE N/A
- Revenue
- TCRX $6,961,000.00
- ABVE $213,446,206.00
- Revenue This Year
- TCRX $255.18
- ABVE N/A
- Revenue Next Year
- TCRX N/A
- ABVE N/A
- P/E Ratio
- TCRX N/A
- ABVE N/A
- Revenue Growth
- TCRX N/A
- ABVE N/A
- 52 Week Low
- TCRX $1.02
- ABVE $0.25
- 52 Week High
- TCRX $6.23
- ABVE $4.40
- Technical
- Relative Strength Index (RSI)
- TCRX 59.09
- ABVE 44.09
- Support Level
- TCRX $1.73
- ABVE $1.82
- Resistance Level
- TCRX $1.95
- ABVE $2.07
- Average True Range (ATR)
- TCRX 0.12
- ABVE 0.15
- MACD
- TCRX 0.01
- ABVE -0.03
- Stochastic Oscillator
- TCRX 84.85
- ABVE 2.22
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.